Induction of cytotoxic and helper T cell responses by modified simian immunodeficiency virus hypervariable epitope constructs

被引:8
作者
Meyer, D [1 ]
Torres, JV [1 ]
机构
[1] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA
关键词
D O I
10.1089/vim.1999.12.117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously reported the broad humoral immunogenicity of peptides synthesized according to the cumulative variability of an epitope (1,16), These peptides, hypervariable epitope constructs (HECs), are designed to represent the envelope glycoproteins of several isolates of the simian immunodeficiency virus (SIV), When HEC peptides were conjugated to palmitic acid and palmitic acid ester (lipoHECs), they promoted the induction of cellular immune responses, SIV envelope lipoHEC immunization of BALB/c and ICR mice resulted in up to 80% cytotoxic T lymphocyte (CTL) lysis of SIV envelope-expressing target cells and SIV envelope-specific delayed type hypersensitivity (DTH). This DTH response was significantly higher than that of single peptide controls, and the response peaked at 24 hours. Strong SIV envelope-specific T-cell proliferative responses were also induced in mice with stimulation indexes higher than 20 for spleen cells and higher than 10 for lymph node cells. Overall, our results demonstrate that conjugation of these variable synthetic peptides to a lipid moiety results in an immunogen capable of inducing strong and cross-reactive cellular immune responses.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 29 条
[1]   HYPERVARIABLE EPITOPE CONSTRUCTS AS A MEANS OF ACCOUNTING FOR EPITOPE VARIABILITY [J].
ANDERSON, DE ;
MALLEY, A ;
BENJAMINI, E ;
GARDNER, MB ;
TORRES, JV .
VACCINE, 1994, 12 (08) :736-740
[2]   SPECIFIC ANTIBODIES ELICITED BY ANTIGEN COVALENTLY LINKED TO A SYNTHETIC ADJUVANT [J].
BESSLER, WG ;
SUHR, B ;
BUHRING, HJ ;
MULLER, CP ;
WIESMULLER, KH ;
BECKER, G ;
JUNG, G .
IMMUNOBIOLOGY, 1985, 170 (03) :239-244
[3]   BIOLOGY OF CLONED CYTO-TOXIC LYMPHOCYTES-T SPECIFIC FOR LYMPHOCYTIC CHORIOMENINGITIS VIRUS - CLEARANCE OF VIRUS INVIVO [J].
BYRNE, JA ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1984, 51 (03) :682-686
[4]  
COLLINS DS, 1992, J IMMUNOL, V148, P3336
[5]   IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN [J].
CULMANNPENCIOLELLI, B ;
LAMHAMEDICHERRADI, S ;
COUILLIN, I ;
GUEGAN, N ;
LEVY, JP ;
GUILLET, JG ;
GOMARD, E .
JOURNAL OF VIROLOGY, 1994, 68 (11) :7336-7343
[6]  
GRANT EP, 1992, J IMMUNOL, V148, P449
[7]  
HART MK, 1991, P NATL ACAD SCI USA, V88, P9948
[8]   AN EPITOPE IN HUMAN IMMUNODEFICIENCY VIRUS-1 REVERSE-TRANSCRIPTASE RECOGNIZED BY BOTH MOUSE AND HUMAN CYTOTOXIC LYMPHOCYTES-T [J].
HOSMALIN, A ;
CLERICI, M ;
HOUGHTEN, R ;
PENDLETON, CD ;
FLEXNER, C ;
LUCEY, DR ;
MOSS, B ;
GERMAIN, RN ;
SHEARER, GM ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2344-2348
[9]   CHARACTERIZATION OF ANTIBODY COVALENTLY COUPLED TO LIPOSOMES [J].
HUANG, A ;
TSAO, YS ;
KENNEL, SJ ;
HUANG, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 716 (02) :140-150
[10]   COLOR TEST FOR DETECTION OF FREE TERMINAL AMINO GROUPS IN SOLID-PHASE SYNTHESIS OF PEPTIDES [J].
KAISER, E ;
COLESCOT.RL ;
BOSSINGE.CD ;
COOK, PI .
ANALYTICAL BIOCHEMISTRY, 1970, 34 (02) :595-&